FC
Fairpointe Capital’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-12,400
| Closed | -$290K | – | 79 |
|
|
2016
Q2 | $290K | Sell |
12,400
-37,450
| -75% | -$876K | 0.01% | 76 |
|
|
2016
Q1 | $938K | Sell |
49,850
-11,800
| -19% | -$222K | 0.02% | 68 |
|
|
2015
Q4 | $1.14M | Sell |
61,650
-2,300
| -4% | -$42.4K | 0.02% | 65 |
|
|
2015
Q3 | $1.05M | Sell |
63,950
-1,300
| -2% | -$21.3K | 0.02% | 66 |
|
|
2015
Q2 | $1.16M | Sell |
65,250
-25,700
| -28% | -$455K | 0.02% | 69 |
|
|
2015
Q1 | $1.61M | Sell |
90,950
-6,100
| -6% | -$108K | 0.02% | 55 |
|
|
2014
Q4 | $1.29M | Buy |
97,050
+29,850
| +44% | +$396K | 0.02% | 60 |
|
|
2014
Q3 | $794K | Hold |
67,200
| – | – | 0.01% | 71 |
|
|
2014
Q2 | $858K | Sell |
67,200
-3,096,873
| -98% | -$39.5M | 0.01% | 69 |
|
|
2014
Q1 | $42.8M | Sell |
3,164,073
-6,780,770
| -68% | -$91.7M | 0.58% | 49 |
|
|
2013
Q4 | $120M | Sell |
9,944,843
-6,264,678
| -39% | -$75.3M | 1.74% | 29 |
|
|
2013
Q3 | $190M | Sell |
16,209,521
-8,683,284
| -35% | -$102M | 3.2% | 3 |
|
|
2013
Q2 | $231M | Buy |
+24,892,805
| New | +$231M | 4.63% | 1 |
|